Exjade

Medicinal product

(Invented) name

Exjade

Active substance (s)

Deferaziroksas

Strength

250 mg

Pharmaceutical form

disperguojamosios tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

V03AC03, Deferasirox

Marketing authorisation holder

Novartis Europharm Ltd., Airija

Date of authorisation

2006-08-28

Date of renewal

Documents

Search in EMA Europe

Stage

Išregistruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Dispersible tablet	1 vnt.
Deferaziroksas	250 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
25487	28093	1028093	lizdinė plokštelė	N28		Receptinis	EU/1/06/356/003	Netiekiama	-	-	No	-	-
25488	28094	1028094	lizdinė plokštelė	N84		Receptinis	EU/1/06/356/004	Netiekiama	-	-	No	-	-
42812	56580	1056580	lizdinė plokštelė	N252		Receptinis	EU/1/06/356/008	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2022-01-24	Išregistruotas
2006-08-28	Registruotas